February 2018 News & Views: PIE Act Is Now Before the Full E&C Committee; CEO Blog: PIE Act Addresses Lag Between FDA Approval, Patient Access; VIDEO: Academy Urges Passage of PIE Act
Leg-Reg Briefing February 2018: PIE Act Before Full House Energy & Commerce Committee AMCP Signs Joint Leer Supporting CREATES Act Bipartisan Budget Act of 2018 Addresses Part D Coverage Gap
The Academy of Managed Care Pharmacy (AMCP) thanks the FDA for the opportunity to provide comments before the Opioid Policy Steering Committee. AMCP commends the FDA for establishing the OPSC and for seeking public input to help identify key areas of focus that the FDA can address.
The Academy of Managed Care Pharmacy (AMCP) is writing to express concerns with specific provisions of House Bill 4472 regarding the regulation of biological products and the substitution of interchangeable biological products when dispensed by pharmacists.
The Academy of Managed Care Pharmacy (AMCP) appreciates the opportunity to submit a letter of support for H.R. 2026 – The Pharmaceutical Information Exchange (PIE) Act of 2017 which will improve patient access to emerging medication therapies and devices by codifying a safe harbor for certain health care economic and scientific information communications between biopharmaceutical and medical device manufacturers and population health decision makers.
The Academy of Managed Care Pharmacy (AMCP) thanks the Centers for Medicare & Medicaid Services for the opportunity to provide comments in response to the proposed rule “Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program [CMS-4182-P]” published in the Federal Register on November 28, 2017.